Cargando…
Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
The main pathophysiology of cerebral ischemia is the structural alteration in the neurovascular unit, coinciding with neurovascular matrix degradation. Resveratrol has been reported to be one of the most potent chemopreventive agents that can inhibit cellular processes associated with ischemic strok...
Autores principales: | Pandey, Anand Kumar, Bhattacharya, Pallab, Shukla, Swet Chand, Paul, Sudip, Patnaik, Ranjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424748/ https://www.ncbi.nlm.nih.gov/pubmed/26170816 http://dx.doi.org/10.4103/1673-5374.155429 |
Ejemplares similares
-
A possible therapeutic potential of quercetin through inhibition of μ-calpain in hypoxia induced neuronal injury: a molecular dynamics simulation study
por: Pandey, Anand Kumar, et al.
Publicado: (2016) -
Corrigendum: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
Publicado: (2020) -
Retraction: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
Publicado: (2022) -
Expression of Concern: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
Publicado: (2021) -
Piroxicam-mediated modulatory action of 5-hydroxytryptamine serves as a “brake” on neuronal excitability in ischemic stroke
por: Bhattacharya, Pallab, et al.
Publicado: (2015)